Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 18k
1 August 2019
E-002503-19
Question for written answer E-002503-19
to the Commission
Rule 138
Mara Bizzotto (ID)

 Subject:  Medicine shortages — legality of export restrictions
 Answer in writing 

The problem of medicine shortages in Europe has reached alarming proportions. All Member States have reported a growing lack of essential medicines, which are now in extremely short supply in pharmacies. Some countries, and lately also Italy, have changed their legislation to ban parallel exports — which undoubtedly exacerbate a multifactorial problem — where there are clear shortages of essential medicines.

On 17 May 2018, the Commission, which, for many years, had been reluctant to recognise the legitimacy of such export restrictions, has at last changed its mind and closed all infringement procedures against the Member States that had implemented them.

Given that, after years of study and working groups, no concrete proposals have been put forward by DG Health, will the Commission:
1. Inform citizens about the outcome of those studies and how the situation can be remedied;
2. Begin, as a matter of urgency, monitoring the activities of the EMA and the national authorities responsible;
3. Amend existing legislation to provide countries with more efficient EU tools in order to counter the situation?
Original language of question: IT 
Last updated: 29 August 2019Legal notice